Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24225260http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24225260http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

To assess serum prolidase enzyme activity and oxidative stress in patients with Behçet's disease (BD).

Methods

The study population consisted of BD patients (n = 42) and healthy participants (n = 29). BD patients were classified as active (n = 18) or inactive (n = 24) according to disease activity. Serum prolidase enzyme activity, total antioxidant status (TAS), total oxidative status (TOS), oxidative stress index (OSI), and malondialdehyde (MDA) levels were measured.

Results

In BD patients with active disease, serum prolidase activity was significantly higher compared with the inactive and control participants. Serum prolidase activity was also significantly higher in all BD patients in comparison with controls. Serum prolidase activity was also positively correlated with OSI, C-reactive protein, and active BD. MDA, TOS, and OSI levels were all significantly higher in the BD group when compared with the healthy control participants. Serum TAS levels were significantly lower in BD patients in comparison with healthy controls.

Conclusion

High prolidase activity may indicate critical biological activities relevant to pathological events in BD, and this activity may be a biological indicator of disease. Further studies are needed to verify these findings."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.org/dc/terms/identifier"doi:10.1179/1351000213y.0000000072"xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Yildiz M."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Yuksel H."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Em S."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Bozkurt M."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Nas K."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Oktayoglu P."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/author"Akdeniz D."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/name"Redox Rep"xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/pages"59-64"xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/title"Serum prolidase enzyme activity and oxidative status in patients with Behcet's disease."xsd:string
http://purl.uniprot.org/citations/24225260http://purl.uniprot.org/core/volume"19"xsd:string
http://purl.uniprot.org/citations/24225260http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24225260
http://purl.uniprot.org/citations/24225260http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24225260
http://purl.uniprot.org/uniprot/#_A0A140VJR2-mappedCitation-24225260http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24225260
http://purl.uniprot.org/uniprot/#_J3K000-mappedCitation-24225260http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24225260
http://purl.uniprot.org/uniprot/#_P12955-mappedCitation-24225260http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24225260
http://purl.uniprot.org/uniprot/A0A140VJR2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24225260
http://purl.uniprot.org/uniprot/P12955http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24225260
http://purl.uniprot.org/uniprot/J3K000http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24225260